Application 016322
- Type
- NDA
- Sponsor
- SCHERING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALISONE | BETAMETHASONE VALERATE | CREAM;TOPICAL | EQ 0.1% BASE | No | No |
| 002 | VALISONE | BETAMETHASONE VALERATE | CREAM;TOPICAL | EQ 0.01% BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N016322-001 | VALISONE | BETAMETHASONE VALERATE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | ||
| N016322-002 | VALISONE | BETAMETHASONE VALERATE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N016322-001 | VALISONE | EQ 0.1% BASE | CREAM / TOPICAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N016322-002 | VALISONE | EQ 0.01% BASE | CREAM / TOPICAL | Approved before 1982 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Valerate | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 7c96b978-25ff-44c2-bc9c-30ff5e34cffb | 2026-03-23 | Warnings, Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 50d4763d-5a84-4c45-be06-040c4a527470 | 2026-03-19 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | bfa4b6f5-3b66-430a-af41-60e3f12982bc | 2026-03-19 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 7281d272-5342-4738-b35c-42570459e9d4 | 2026-02-04 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | 2026-01-28 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 3c85be0f-2731-44f1-a18e-d3852d54846f | 2025-10-02 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Limited | 75d70e76-023c-4a00-954d-79a697bed80f | 2025-09-25 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 985d1f62-4bff-4bf1-b7c7-96cb456ef83d | 2025-02-07 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 02db1402-701c-483c-bfd6-8b7a543ae8ef | 2024-11-11 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Inc. | 3b6fa573-de04-4626-a39a-dca39def6df2 | 2024-08-23 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | a2154b33-0f61-49af-e053-2995a90a1810 | 2024-06-20 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | 64badc1a-8922-c6e3-e053-2991aa0a8b1c | 2024-06-06 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Padagis Israel Pharmaceuticals Ltd | dc5dfd3e-7762-40c8-880e-c7db80d87749 | 2024-03-31 | Warnings, Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | f8711d17-de6a-45e3-8027-b650308207ed | 2023-12-15 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | d265d143-343f-41ec-9cb4-18d83edb772b | 2023-12-12 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 036706f1-0a24-4765-9a62-820ad64934be | 2022-06-01 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Cosette Pharmaceuticals, Inc. | 784476d2-5e5c-fdba-a677-8973a777b5ef | 2022-05-05 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 2a64b65b-8a49-45ea-9464-2269751c075c | 2021-04-01 | Adverse reactions | BETAMETHASONE VALERATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.